Abstract:We thank Feng et al 1 for their interest in our manuscript reporting the results of the PERICLES trial. 2 In this phase II trial, patients with stage IV penile cancer were treated with atezolizumab (anti-PD-L1) with or without radiotherapy (RT).Patients with penile cancer with locoregional metastasis experience a high rate of metastasis-associated morbidity and often have rapid progression. 3,4 We, therefore, felt that therapy aimed at locoregional control was needed in the subset of patients at risk for locor… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.